Case number 1:19-cv-00105
Genentech, Inc. et al v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 20, 2021 | 18 | Order (2) |
| Oct 20, 2021 | 18 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,383,150 B2;8,420,674 B2; 8,592,462 B2; 8,609,701 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2; 9,561,217 B2. (Attachments: # (1) Order)(nms) |
| Oct 20, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 336 in Lead Civil Action 19-78-RGA. (nms) |
| Sep 6, 2019 | 17 | Transcript (41) Docket Text: Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/27/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/5/2019. (Triozzi, Heather) |
| Sep 3, 2019 | 16 | Scheduling Order (16) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Sep 3, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) |
| Aug 30, 2019 | 15 | Cover Letter (1) |
| Aug 30, 2019 | 15 | Main Document (19) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). |
| Aug 20, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) |
| Aug 16, 2019 | 14 | Main Document (26) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). |
| Aug 16, 2019 | 14 | Letter to The Honorable Richard G. Andrews (2) |
| May 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Mar 13, 2019 | 12 | Answer to Counterclaim (12) Docket Text: ANSWER to [10] Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Blumenfeld, Jack) Modified on 3/13/2019 (nms). |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) |
| Feb 20, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma USA, Inc. for Aurobindo Pharma Limited filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Feb 20, 2019 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Genentech, Inc., InterMune, Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Dorsney, Kenneth) |
| Feb 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Feb 11, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Jan 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 19-cv-103-RGA, 8 in 19-cv-105-RGA) STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to February 20, 2019. Signed by Judge Richard G. Andrews on 1/29/2019. Associated Cases: 1:19-cv-00103-RGA, 1:19-cv-00105-RGA(nms) |
| Jan 29, 2019 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. to answer, move or otherwise respond to the Complaint to February 20, 2019 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Jan 23, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00103-RGA through 1:19-cv-00105-RGA and 1:19-cv-00109-RGA through 1:19-cv-00111-RGA (rjb) |
| Jan 23, 2019 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 1/24/2019 (nms). |
| Jan 18, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 1/18/2019; Aurobindo Pharma USA, Inc. on 1/18/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Jan 18, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Aurobindo Pharma USA, Inc. served on 1/18/2019, answer due 2/8/2019. (Blumenfeld, Jack) |
| Jan 17, 2019 | 1 | Main Document (43) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2547236.) - filed by InterMune, Inc., Genentech, Inc.. (Attachments: # (1) Exhibit 1-16, # (2) Civil Cover Sheet)(lak) |
| Jan 17, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc.; Other Affiliate Genentech, Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc.. (lak) |
| Jan 17, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark - See attachment for numbers. (lak) |
| Jan 17, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/6/2018. Date of Expiration of Patent: See attachment.Thirty Month Stay Deadline: 4/15/2022. (lak) |
| Jan 17, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Jan 17, 2019 | 1 | Civil Cover Sheet (1) |
| Jan 17, 2019 | 1 | Exhibit 1-16 (228) |
| Jan 17, 2019 | 1 | Complaint* (1) |
